The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial is a research paper published in EBioMedicine (2022). On theSindex it has a DataRank of 0.659. It has been cited 80 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.659
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Veterans Affairs
Grant: I01BX005595
National Institutes of Health
Grant: F30CA236031
National Institutes of Health
Grant: R01CA265997
National Institutes of Health
Grant: R21CA255291
FWCI
6.80
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals